Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing ventral prostate tumorous lesions during a period of time
go back to main search page
Accession:CMO:0000943 term browser browse the term
Definition:The number of individuals in a study population which develop new instances of tumorous lesions of the ventral prostate during a certain period compared to the total number of individuals in the study population, expressed as a percentage. A tumorous lesion is one which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells.
Synonyms:related_synonym: ventral prostate tumorous lesion incidence



show annotations for term's descendants           Sort by:
percentage of study population developing ventral prostate tumorous lesions during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Prcs1 Prostate cancer susceptibility QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr19:15,114,598...34,521,833 JBrowse link
Q Prcs2 Prostate cancer susceptibility QTL 2 IDA RGD PMID:15805257 RGD:1358944 NCBI chr20:4,606,607...17,617,956 JBrowse link

Related Phenotype Data for Term "percentage of study population developing ventral prostate tumorous lesions during a period of time" (CMO:0000943)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        organ tumorous lesion incidence/prevalence measurement 18
          prostate tumorous lesion incidence/prevalence measurement 2
            percentage of study population developing prostate tumorous lesions during a period of time 2
              percentage of study population developing ventral prostate tumorous lesions during a period of time 2
                percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time 0
                percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          prostate tumorous lesion measurement 4
            prostate tumorous lesion incidence/prevalence measurement 2
              percentage of study population developing prostate tumorous lesions during a period of time 2
                percentage of study population developing ventral prostate tumorous lesions during a period of time 2
                  percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time 0
                  percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time 0
paths to the root